Incidence, potential risk factors and clinical impacts of incomplete device endothelialization - Video

Published On 2022-03-26T17:45:19+05:30 | Updated On 29 March 2022 11:54 AM IST

Overview

Atrial fibrillation (AF) is known to cause a 4- to 5-fold increased risk of ischemic stroke. Oral anticoagulation with non-vitamin K oral anticoagulants (NOACs) or vitamin K antagonists are popularly recommended first-line treatment for reducing stroke risk, but bleeding complications and nonadherence are barriers to effective anticoagulation therapy.

Device related thrombus (DRT) formation, one of the main concerns after LAAC, is generally reported to be 2–5% cases. Especially, it may develop on the poorly endothelialized device following intervention, and have a potential negative impact on the risk of stroke and thromboembolic events. Now, what poses as risk factors of incomplete device endothelialization?

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751